CTP-6: Phase III started

Celltrion began a double-blind, international Phase III trial to evaluate paclitaxel plus 8 mg/kg CTP-6 or 8 mg/kg Herceptin in 526 patients. CTP-6 is a biosimilar version of Herceptin trastuzumab, w...